Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

Neuphoria Therapeutics shares closed up in their first Nasdaq trading day after Bionomics re-domiciled to the U.S. from Australia and Neuphoria became the ultimate parent company of Bionomics. The ...

Bionomics ( ) has issued an update. Neuphoria Therapeutics Inc. has completed its redomiciliation, transferring governance from Bionomics’ organizational documents to Neuphorias ...

Neuphoria Therapeutics Inc., a Delaware corporation, has successfully completed the redomiciliation process of Bionomics Limited, an Australian corporation, on December 23, 2024. This transformative ...

Bionomics Limited has announced that its shareholders have approved the re-domiciliation of the company from Australia to the United States, converting it into a Delaware corporation under ...

ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company) is pleased to announce that the Supreme Court of New South Wale ...

ADELAIDE, Australia, and CAMBRIDGE, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel ...

Bionomics (BNOX) announced that the Supreme Court of New South Wales, Australia has made orders approving the scheme of arrangement in relation to the company’s proposed re-domiciliation from ...

Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”) is pleased to announce that its previously announced scheme of arrangement ...

Dec. 09, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...